The Menin - MLL inte... 申请号：JP2018564288 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cance...
The Listings Generat... 申请号：AU2012101582 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
The Listings Generator will allow Real Estate Agents to reach and connect with even more vendors in the area. This unique marketing system is designed to : ultimately increase listings & therefore in...
The L1 protein mutat... 申请号：JP2018548263 专利类型：发明申请 公开（公告）日：2016-12-02
状态：寻求转化 转让价格：面议
Provided are a mutated HPV58 L1 protein or a variant thereof, a sequence encoding the same, a method for preparing the same, and a virus-like particle comprising the same, wherein the protein or a...
The FXR agonists for... 申请号：JP2018544176 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
The invention provides methods for modulating the activity of farnesoid X receptors (FXRs) using specific FXR agonists, in particular for treating or preventing liver and gastrointestinal diseases.
The FXR agonists for... 申请号：JP2018544147 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
The invention provides methods for modulating the activity of farnesoid X receptors (FXRs) using specific FXR agonists, in particular for treating or preventing liver diseases and disorders.
The FXR agonist ARB ... 申请号：JP2018508007 专利类型：发明申请 公开（公告）日：2017-03-27
状态：寻求转化 转让价格：面议
The present invention provides an NASH therapeutic agent including : an FXR agonist, preferably obeticholic acid or a pharmaceutically acceptable salt thereof; and an ARB or a pharmaceutically acce...
The Electronic Locki... 申请号：DE19528099 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
The electronic locking system with a a for intended operating electronics serving (14) containing key (2) and associated signal processors with closable parts, wherein the key (2) via transmission/re...
The ELP for sustaine... 申请号：JP2018557415 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
The present disclosure provides pharmaceutical formulations for sustained release, and methods for delivering a treatment regimen with a combination of sustained release and long half-life formulatio...
The CDK inhibitors f... 申请号：JP2016537859 专利类型：发明授权 公开（公告）日：2014-08-28
状态：寻求转化 转让价格：面议
The present invention relates to a pharmaceutical combination comprising, separately or together, (1) a first agent which is an ALK inhibitor or a pharmaceutically acceptable salt thereof and (2) a ...
The BTK inhibitors i... 申请号：JP2016525051 专利类型：发明授权 公开（公告）日：2014-10-21
状态：寻求转化 转让价格：面议
The present invention relates to pyridine, pyrimidine, pyrazine, and pyridazine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.
